Adc Therapeutics SA 8-K filings

NYSE

24 Jan 2024

ADCT

8-K: ADC Therapeutics and Redmile Group Reach Agreement on Preemptive and Advance Subscription Rights

ADC Therapeutics has entered into an agreement with Redmile Group regarding preemptive and advance subscription rights, clarifying the conditions under which Redmile's rights can be restricted.

NYSE

19 Jan 2024

ADCT

Adc Therapeutics SA

8-K: ADC Therapeutics Amends Loan Agreement, Easing Out-Licensing Terms and Setting ZYNLONTA Sales Targets

ADC Therapeutics has amended its loan agreement, reducing the percentage of out-licensing proceeds required for debt repayment and establishing minimum sales targets for ZYNLONTA.